Ex Parte HarttigDownload PDFPatent Trials and Appeals BoardJun 18, 201913669952 - (D) (P.T.A.B. Jun. 18, 2019) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/669,952 11/06/2012 23690 7590 06/20/2019 ROCHE DIAGNOSTICS OPERATIONS INC. 9115 Hague Road Indianapolis, IN 46250-0457 FIRST NAMED INVENTOR Herbert Harttig UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 26659US-dc 6369 EXAMINER HOEKSTRA, JEFFREY GERBEN ART UNIT PAPER NUMBER 3791 NOTIFICATION DATE DELIVERY MODE 06/20/2019 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): j ackie.pike@roche.com pair_roche@firsttofile.com meg.ward@roche.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte HERBERT HARTTIG 1 Appeal 2017-011205 Application 13/669,952 Technology Center 3700 Before RICHARD M. LEBOVITZ, JOHN G. NEW, and RACHEL H. TOWNSEND, Administrative Patent Judges. NEW, Administrative Patent Judge. DECISION ON APPEAL 1 Appellant identifies Roche Diabetes Care, Inc. as the real party-in-interest. App. Br. 2. Appeal 2017-011205 Application 13/669,952 SUMMARY Appellant files this Appeal under 35 U.S.C. § I34(a) from the Examiner's Final Rejection of claims 1-12 and 17. Specifically, claims 1-2, 4--7, and 9-12 stand rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Boecker et al. (US 2003/0199893 Al, October 23, 2003) ("Boecker"), Raney et al. (US 2004/0116829 Al, June 17, 2004) ("Raney"), and Davis et al. (US 2007 /0031283 Al, February 8, 2007) ("Davis"). Claim 3 stands rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Boecker, Raney, Davis, and Ditter et al. (US 5,846,422, December 8, 1998) ("Ditter"). Claim 8 stands rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Boecker, Raney, Davis, and Gofman et al. (US 2009/0149725 Al, June 11, 2009) ("Gofman"). Claim 17 stands rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Raney and Harman et al. (US 2007/0232956 Al, October 4, 2011) ("Harman"). Claim 17 also stands rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Raney and Calasso et al. (US 2007/0016103 Al, January 18, 2007) ("Calasso"). We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM-IN-PART. 2 Appeal 2017-011205 Application 13/669,952 NATURE OF THE CLAIMED INVENTION Appellant's invention is directed to a lancet magazine which includes a housing and a plurality of lancets each of which is enclosed in a sterile chamber of the housing. Abstr. REPRESENTATIVE CLAIM Claim 1 is illustrative of the claims on appeal and recites: 1. A lancet magazine, comprising a housing and a plurality of lancets each of which is enclosed in a sterile chamber of the housing, wherein the chambers each have a puncturing opening which is closed with a foil, wherein the lancets comprise a sample receiving device for receiving body fluid and the chambers each comprise a further opening which is closed with a membrane that is permeable to gas and fluid and comprises a lower side that faces the lancet and serves to receive body fluid from the sample receiving device and an upper side that serves to transfer body fluid to a test field arranged on the membrane. App. Br. 19. ISSUES AND ANALYSES We are persuaded by, and expressly adopt, the Examiner's findings, reasoning, and conclusion that Appellant's claims are primafacie obvious over the combined cited prior art. We address the arguments raised by Appellant below. 3 Appeal 2017-011205 Application 13/669,952 A. Claims 1-12 i Issue 1 Appellant argues that the Examiner erred in finding that Boecker teaches both a "puncturing opening" and a "further opening which is closed with a membrane that is permeable to gas and fluid," as required by claim 1 App. Br. 7-8. Analysis The Examiner finds that Boecker teaches a lancet magazine, comprising a housing and a plurality of lancets each of which is enclosed in a sterile chamber of the housing. Final Act. 3 ( citing Boecker ,r,r 84--85, Figs. 1, 11 ). The Examiner finds that Boecker teaches that chambers each have a puncturing opening which is closed with a foil, and that the lancets within each comprise a sample receiving device for receiving body fluid. Id. (citing Boecker ,r,r 85, 114). The Examiner also finds that the chambers each comprise a further opening closed by a membrane (barrier 438) and comprises a lower side that faces the lancet and serves to receive body fluid from the sample receiving device, in which the sensing elements may be formed on the top of the penetrating member cartridge, including electrochemical or optical detection. Id. at 3--4 ( citing Boecker claims 10, 11, ,r,r 109, 169). Appellant argues that the Examiner relies on barrier 254 or barrier 438 of Boecker as teaching the limitation of claim 1 reciting a: "further opening 2 Appellant argues dependent claims 3 and 8 together with claims 1-2, 4--7, and 9-12. See App. Br. 7. 4 Appeal 2017-011205 Application 13/669,952 which is closed with a membrane that is permeable to gas and fluid." App. Br. 8 ( citing Final Act. 3). Appellant contends that each of these foil/membranes (i.e., items 28, 254, and 438) taught by Boecker are the same barrier structure pictured in different embodiments of the penetrating membrane cartridge. Id. Specifically, Appellant argues that barriers 28, 254, and 438 are each essentially the same element of different embodiments in which each covers the top surface of the penetrating member 18, 262, and 436 respectively. Id. Therefore, Appellant contends, Boecker does not "teach two separate openings that are each closed with a foil and[,] separately[,] a membrane as was alleged in the Office Action and as claimed in claim 1." Id. at 9. We are not persuaded by Appellant's argument. Figure 18 of Boecker is reproduced below: Figure 18 of Boecker depicts an embodiment of a lancing device having features of the invention With respect to Figure 18, Boecker teaches: The penetrating member cartridge 244 has a plurality of penetrating member slots 252 disposed in a radial configuration in a top surface 254 a base plate 256 of the penetrating member cartridge 244. The distal ends 253 of the penetrating member 5 Appeal 2017-011205 Application 13/669,952 slots 252 are disposed at an outer surface 260 of the base plate 256. A fracturable sterility barrier 258, shown partially cut away, is disposed on the top surface 254 of base plate 256 over the plurality of penetrating member slots 252. The sterility barrier 258 is also disposed over the outer surface 260 of the base plate 256 in order to seal the penetrating member slots from contamination prior to a lancing cycle. A distal portion of a penetrating member 262 is shown extending radially from the penetrating member cartridge 244 in the direction of a patient's finger 264. Boecker ,r 109. Thus each penetrating member slot 252 is sealed from contamination prior to a lancing cycle by a portion of the sterility barrier 258. Boecker thus expressly teaches a "puncturing opening" 252 covered with a foil through which a penetrating member passes as it emerges from the cartridge. The puncturing openings are separated from one another and each opening is covered with a segment of the sterility barrier 258 which only is punctured when a lancet in the respective opening is moved forward past the barrier, thus meeting the claim requirement that "the chambers each have a puncturing opening which is closed with a foil." With respect to the "further opening which is closed with a membrane that is permeable to gas and fluid," the Examiner relies on the combination of Boecker and Davis. Boecker teaches: In another embodiment of the present invention, a manufacturing method provides a cartridge that has a plurality of cavities at least partially holding a plurality of penetrating members. The cartridge is sterilized while each of the cavities is in a sealed condition. Sensors are added to the cavities by opening cavities in a sterile environment, coupling a sensor layer to the cartridge that provides the sensors, and resealing the cavities to maintain a sterile environment. Boecker ,r 20. More specifically, Boecker teaches: 6 Appeal 2017-011205 Application 13/669,952 In another embodiment as seen in FIG. 72, sensing elements 760 may be directly printed or formed on the top of bottom of the penetrating member cartridge 700, depending on orientation. The bare penetrating member 720 is then actuated through a hole 762 in the plastic facing, withdrawn into the radial cavity followed by the blood sample. Electrochemical or optical detection for analyte sensing may then be carried out (FIG. 72). Again the cavity 766 may have a clear portion to allow light to pass for optical sensing. In one embodiment, a multiplicity of miniaturized sensor fields may be placed on the floor of the radial cavity as shown in FIG. 72 or on the microfluidic module shown in FIG. 71 to allow many tests on a single analyte form a single drop of blood to improve accuracy and precision of measurement. Although not limited in this manner, additional sensor fields or regions may also be included for calibration or other purposes. Id. at ,r 169. Figure 72 of Boecker is reproduced below: ! !/ ' ----, I\..___ ____ _ I ,,.,, ------------------------- /L _1 __ , V Figure 72 of Boecker depicts a sample module with still further embodiments of a cartridge according to the present invention. Boecker further teaches: If the cartridge 800 uses a sensor arrangement where the sensors are on a substrate attached to the bottom of the cartridge, there 7 Appeal 2017-011205 Application 13/669,952 may be through holes (as shown in FIG. 76), wicking elements, capillary tube or other devices on the cartridge 800 to allow body fluid to flow from the cartridge to the sensors 808 for analysis. In other configurations, the sensors 808 may be printed, formed, or otherwise located directly in the cavities housing the penetrating members 802 or areas on the cartridge surface that receive blood after lancing. Id. at ,I 175. Boecker thus expressly teaches: "a further opening ... comprising a lower side that faces the lancet and serves to receive body fluid from the sample receiving device and an upper side that serves to transfer body fluid to a test field," as recited in claim 1. However, Boecker does not expressly teach that the opening is: "closed with a membrane that is permeable to gas and fluid and comprises a lower side that faces the lancet and serves to receive body fluid from the sample receiving device and an upper side that serves to transfer body fluid to a test field arranged on the membrane," as recited in claim 1. The Examiner acknowledges that Boecker does not teach: "a further opening which is closed with a membrane that is permeable to gas and fluid," as recited in claim 1. Ans. 7. However, the Examiner relies, inter alia, upon Davis as teaching this limitation, additionally finding that: "Davis explicitly teaches using filter material with pores sized of 0.2 micrometers to exclude viruses and later particles, i.e.[,] bacterial." Id. at 9 ( citing Davis i-fi-fl30, 136, 17, 247-251). We agree. Davis teaches: Cartridge 202 can also be operative to detect and/or record events or environmental conditions relating to sample collection, including but not limited to the presence of a sample within cartridge 202, the environment temperature, humidity, exposure 8 Appeal 2017-011205 Application 13/669,952 of the sample to oxygen, and the number of test cartridge- interfaces. As illustrated in FIG. 2, cartridge 202 can comprise one or more interfaces 204 that can align with instrument 100 so that an analysis of the sample can be performed. Interface 204 can be provided in various manners consistent with the principles known in the art. For example, depending on the technique used by the apparatus, interface 204 can comprise a gas permeable, liquid permeable membrane, solid membrane, or a mesh area. Interface 204 can be located at any location on cartridge 202 allowing the apparatus the access to the sample necessary to perform a test on the sample. Davis ,r,r 129--130. Davis thus expressly teaches a: "a further opening which is closed with a membrane that is permeable to gas and fluid," as recited in claim 1, and that the combination of the cited prior art teaches or suggests the limitations disputed by Appellant. Issue 2 teach: Appellant argues that the Examiner erred because Raney does not the chambers each comprise a further opening which is closed with a membrane that is permeable to gas and fluid and comprises a lower side that faces the lancet and serves to receive body fluid from the sample receiving device and an upper side that serves to transfer body fluid to a test field arranged on the membrane, as claimed in claim 1. App. Br. 8. Analysis We do not find Appellant's argument persuasive because, as we have explained supra, the Examiner also relies upon Davis as teaching this 9 Appeal 2017-011205 Application 13/669,952 limitation, and we agree with the Examiner's findings, reasoning and conclusion with respect to the latter. See Final Act. 5; Ans. 9. Issue 3 Appellant argues that Davis fails to teach the limitation of claim 1 reciting: "the chambers each comprise a further opening which is closed with a membrane that is permeable to gas and fluid and comprises a lower side that faces the lancet and serves to receive body fluid from the sample." App. Br. 10-11. Analysis Appellant argues that the Examiner finds that "Davis teaches a sampling cartridge [202] having a top surface having a sensor interface 204 which can comprises a gas, liquid permeable membrane." App. Br. 11 ( quoting Final Act. 5). According to Appellant, in the embodiment taught in Davis, the interface 204 is designed to interact with an instrument 100 for sample analysis, and the interface 204 of cartridge 202 is formed such that the apparatus can interact with a sample without physically contacting it: "The material forming interface 204 of cartridge 202, which allows the apparatus to interact with the sample without physically contacting it, can vary depending on the assay technique employed by instrument 100." Id. ( quoting Davis ,r 23 8). Appellant contends that such a membrane would not be suitable to transfer body fluid to a test field arranged on the membrane, as claimed in claim 1. Id. We are not persuaded. Appellant does not address the teaching of Davis quoted supra, which expressly teaches that: 10 Appeal 2017-011205 Application 13/669,952 For example, depending on the technique used by the apparatus, interface 204 can comprise a gas permeable, liquid permeable membrane, solid membrane, or a mesh area. Interface 204 can be located at any location on cartridge 202 allowing the apparatus the access to the sample necessary to perform a test on the sample. Davis ,r 130. In this embodiment, Davis expressly teaches the use of a gas and liquid permeable membrane, as recited in claim 1, at the interface between the sample and the sensor. "[A]ll disclosures of the prior art, including unpreferred embodiments, must be considered." In re Lamberti, 545 F.2d 747, 750 (C.C.P.A. 1976). Issue 4 Appellant contends that a person of ordinary skill in the art would not have combined the teachings of the cited prior art to arrive at Appellant's claimed invention. App. Br. 11. Analysis Appellant contends that a person of ordinary skill in the art would not have been compelled to modify Boecker to make a further opening which is closed with a membrane that is permeable to gas and fluid and comprises a lower side that faces the lancet and serves to receive body fluid from the sample receiving device and an upper side that serves to transfer body fluid to a test field arranged on the membrane, as recited in claim 1. App. Br. 12. Appellant contends that Boecker teaches a lancet magazine comprising chambers that are sealed by a single sterilization barrier and contain lancets. Id. According to Appellant, one embodiment of Boecker teaches a sensing element 7 60 can be directly 11 Appeal 2017-011205 Application 13/669,952 printed or formed on the top or bottom of the cartridge 700. Id. (citing Boecker, ,r 169, Fig. 72). Appellant asserts that the inclusion of sensing element 7 60 onto the top of the cartridge would require the sensing element to be in contact with the cavity (i.e., a clear portion for optical sensing, or a test element for exposure to the substance to be tested. Id. Appellant argues that Raney could not have been readily combined with Boecker by a person skilled in the art because the incorporation would have changed their respective functions. App. Br. 11 ( citing MPEP § 2143). According to Appellant, the device in Raney is a "capillary suction device" for testing blood, in which the test reagent 24 is found within the device, instead of outside the magazine as claimed, and the purpose of the absorbent material 23 is simply to wick the test liquid. Id. Appellant contends that inclusion of such an absorbent material would also serve to defeat the sterility of the sterile chamber in the housing as also is required in claim 1. Id. at 11-12. Appellant argues that, although the Examiner finds that the device of Boecker does not need to be sterile, such a limitation for a sterile chamber is claimed in claim 1. Id. at 12 (citing (Final Act. 16). Appellant argues that Davis discloses an assay cartridges 202 comprising a chamber that is closed by a permeable membrane 204. App. Br. 13. According to Appellant, testing of the sample within the chamber may be accomplished with a test field within the chamber, or though connection to an apparatus 100. Id. Appellant contends that, although the Examiner has stated that the reason to combine Davis is to facilitate the analysis of collected samples, such an inclusion would at the best not facilitate, and would most likely hinder, analysis by getting between the clear window or the test element of Boecker. Id. 12 Appeal 2017-011205 Application 13/669,952 We are not persuaded by Appellant's arguments. We have explained supra why we conclude that the combination of at least Boecker and Davis teach or suggest all of the limitations of claim 1. The Examiner finds that the principle of operation and function of the devices taught by each of the references is to collect and analyze an analyte in blood. Ans. 12. The Examiner finds that the proposed combinations are capable of performing the intended function of collecting and sampling an analyte. Id. We agree. Appellant's argument against combining the teachings of Boecker and Davis is that the inclusion of the latter's gas and liquid membrane between the substrate and chamber of Boecker would at best not facilitate, and would most likely hinder, analysis by getting between the clear window or the test element of Boecker. App. Br. 13. Appellant offers no evidence in support of this argument. Indeed, Davis neither teaches nor suggests that the inclusion of such a membrane hinders or otherwise interferes with analysis of a sample between the sensor and the chamber into which it is drawn. See Davis ,r,r 129-130. Attorney arguments and conclusory statements that are unsupported by factual evidence are entitled to little probative value. In re Geisler, 116 F .3d 1465, 1470 (Fed. Cir. 1997). We consequently affirm the Examiner's rejection of claims 1-12. B. Issue Claim 1 7 over Raney and Harman Independent claim 1 7 recites: 17. A method comprising: 13 Appeal 2017-011205 Application 13/669,952 transporting a body fluid sample from a lancet on one side of a membrane to a test field on the other side of the membrane, the step of transporting comprises: contacting the lancet having the body fluid sample with the inner side of the membrane, and delivering the body fluid sample through the membrane to the test field by capillary forces; wherein the membrane is permeable to gas and fluid and is configured to close an opening of a chamber of a lancet magazme. App. Br. 20. Appellant argues that the device of Harman cannot be combined with the membrane and test field of Raney because it would alter the intended function of Harman. 3 App. Br. 14. Analysis The Examiner finds that Harman teaches, inter alia, a method comprising: transporting a body fluid sample from a lancet on one side of a sensor to a test field on the other side of the membrane, the step of transporting comprises: contacting the lancet having the body fluid sample with the inner side of the sensing member, and the sensor positioned in an 3 Appellant also asserts that: "all of the teachings of claim 1 7 are not present in the cited references." App. Br. 14. However, Appellant makes no argument and adduces no evidence in support of this assertion. We consequently do not find Appellant's conclusory statement persuasive. See In re Lovin, 652 F.3d 1349, 1357 (Fed. Cir. 2011) ("[W]e hold that the Board reasonably interpreted Rule 41.3 7 to require more substantive arguments in an appeal brief than a mere recitation of the claim elements and a naked assertion that the corresponding elements were not found in the prior art"). 14 Appeal 2017-011205 Application 13/669,952 opening of a chamber of a lancet magazine (chamber 24). Final Act. 9 (citing Harman ,r 113, Fig. 2). The Examiner finds Harman also teaches the use of an optical sensing means. Id. (citing Harman ,r 147). The Examiner finds that Raney teaches an analyte sensor for a lancet mechanism comprising a membrane, in which fluid is delivered from one side of a membrane to a test field on the other side of the membrane comprising delivering the body fluid sample through the membrane to the test field by capillary forces. Final Act. 9. The Examiner finds that Raney teaches that the membrane is permeable to gas and fluid and is configured to close an opening of a chamber of a lancet magazine (i.e., the absorbent material transfers fluid to a reagent 24 on a top side of the absorbent material). Id. (citing Raney ,r 44). The Examiner finds that Raney teaches that the fluid moves to the test area 18 by, e.g., wicking into an absorbent material 23, and there contacts the test reagent 24 positioned on top of the wicking material para 79, the wicking material closing an opening in the magazine 18. Id. (citing Raney ,r,r 79--84, Figs. 1--4). The Examiner also points to Roe (2010/0145228 Al, June 10, 2010) ("Roe")4 as teaching the combination of the sensor closing an opening of a chamber of a lancet magazine. Final Act. 10 ( citing Roe ,r 30, Fig. 7). The Examiner concludes that it would have been obvious to a person of ordinary skill in the art to modify the device taught by Harman to include an optical sensor, as taught by Raney, on the top surface of the cartridge to 4 The instant application was filed on November 6, 2012, and claims, ultimately, the priority benefit of European Patent Application, EPO 10004776.0, filed May 6, 2010. See Spec. ,r 1. Roe was filed June 10, 2010, and thus does not qualify as prior art to the instant application. 15 Appeal 2017-011205 Application 13/669,952 provide a suitable conventional means for determining a blood analyte parameter by substituting one suitable sensing means for another. Final Act. 10 (citing Raney ,r,r 13, 80). We are not persuaded that the Examiner has established a prima facie case of obvious over the cited prior art with respect to claim 17. Raney teaches a device in which fluid from a wound caused by a lancet is drawn into a channel by capillary action and then enters a test chamber, by wicking into an absorbent material, and then comes in contact with the sensor. See Raney Figs. 1--4, ,r,r 43--45. Raney does not teach or suggest a: "membrane [that] is permeable to gas and fluid and is configured to close an opening of a chamber of a lancet magazine," and we decline to include in that limitation the "absorbent material" of Raney, because such an absorbent material does not necessarily have the selectivity (i.e., "permeable to gas and fluid" but not, presumably, to cells or macromolecules) recited in the limitation. Furthermore, Harman does not teach or suggest a membrane between the sensor and the fluid withdrawn from the wound. Because the Examiner has not shown that the cited prior art teaches or suggests all of the limitations recited in claim 17, we conclude that the Examiner has not established a prima facie case of obviousness, and we reverse the rejection. C. Claim 1 7 over Raney and Calasso Analysis We similarly conclude that the Examiner has failed to establish a prima facie case of obviousness over Raney and Calasso. We have discussed the relevant teachings of Raney supra. Calasso teaches a: 16 Appeal 2017-011205 Application 13/669,952 [b Jody fluid sampling device comprising a skin-piercing element having a collection zone for receiving body fluid, and the device further comprising a fluid receiving means remote spaced apart from the collection zone so that body fluid in the collection zone will not contact the fluid receiving means initially .... The fluid receiving means may have a test zone for performing an analytical reaction. Fluid sample from the collection zone is automatically or manually transported to the fluid receiving means to contact the fluid with the test zone. Calasso Abstr. However, Calasso contains no teaching or suggestion of a membrane permeable to gas and liquid separating the sampled fluid from the sensor surface. Because the Examiner has not shown that the cited prior art teaches or suggests all of the limitations recited in claim 17, we conclude that the Examiner has not established a prima facie case of obviousness, and we reverse the rejection. DECISION The Examiner's rejection of claims 1-12 and 17 under 35 U.S.C. § 103(a) is affirmed. The Examiner's rejection of claim 17 under 35 U.S.C. § 103(a) is reversed. No time period for taking any subsequent action in connection with this appeal maybe extended under 37 C.F.R. § 1.136(a)(l). See 37 C.F.R. § 1.136(a)(l )(iv). AFFIRMED-IN-PART 17 Copy with citationCopy as parenthetical citation